However, in a study (191) of predictive factors for relapse after treatment in 108 bone marrow preparations from 36 children with stage IV neuroblastoma, the degree of Bn immunoreactivity was not significant, whereas chromogranin A and NPY expressions were highly predictive of an unfavorable response. Here, GRP is linked to neuroblastoma.